Simplex Trading
VNDA icon

Simplex Trading’s Vanda Pharmaceuticals VNDA Stock Holding History

Simplex Trading’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$158K Sell
22,800
-11,500
-34% -$88.7K ﹤0.01% 4584
2025
Q4 		$303K Sell
34,300
-101,000
-75% -$556K ﹤0.01% 3806
2025
Q3 		$675K Sell
135,300
-109,200
-45% -$506K ﹤0.01% 3474
2025
Q2 		$1.15M Buy
244,500
+134,200
+122% +$587K ﹤0.01% 2632
2025
Q1 		$506K Buy
110,300
+98,400
+827% +$459K ﹤0.01% 3393
2024
Q4 		$57K Buy
11,900
+8,700
+272% +$41.8K ﹤0.01% 5752
2024
Q3 		$15K Sell
3,200
-31,800
-91% -$170K ﹤0.01% 6924
2024
Q2 		$197K Buy
35,000
+31,100
+797% +$161K ﹤0.01% 4667
2024
Q1 		$16K Buy
3,900
+2,700
+225% +$10.8K ﹤0.01% 7294
2023
Q4 		$5K Buy
+1,200
New +$4.84K ﹤0.01% 7914
2023
Q3 		– Sell
-200
Closed -$1K – 9937
2023
Q2 		$1K Sell
200
-2,300
-92% -$14.7K ﹤0.01% 8749
2023
Q1 		$16K Sell
2,500
-200
-7% -$1.41K ﹤0.01% 7154
2022
Q4 		$19K Buy
+2,700
New +$26.3K ﹤0.01% 6941
2022
Q2 		– Sell
-2,400
Closed -$27K – 11198
2022
Q1 		$27K Buy
2,400
+2,100
+700% +$27.6K ﹤0.01% 7911
2021
Q4 		$4K Sell
300
-1,800
-86% -$31.4K ﹤0.01% 9724
2021
Q3 		$44K Hold
2,100
– – ﹤0.01% 7664
2021
Q2 		$45K Buy
2,100
+2,005
+2,111% +$35.9K ﹤0.01% 7780
2021
Q1 		$142K Sell
95
-14
-13% -$227 ﹤0.01% 5256
2020
Q4 		$143K Sell
109
-81
-43% -$975 ﹤0.01% 5047
2020
Q3 		$183K Buy
190
+5
+3% +$53 ﹤0.01% 4229
2020
Q2 		$211K Sell
185
-196
-51% -$2.22K ﹤0.01% 3939
2020
Q1 		$394K Buy
381
+274
+256% +$3.4K ﹤0.01% 2848
2019
Q4 		$175K Buy
107
+102
+2,040% +$1.54K ﹤0.01% 3903
2019
Q3 		$6K Sell
5
-17
-77% -$237 ﹤0.01% 6549
2019
Q2 		$30K Buy
22
+18
+450% +$286 ﹤0.01% 5281
2019
Q1 		$7K Sell
4
-34
-89% -$775 ﹤0.01% 6358
2018
Q4 		$99K Buy
38
+31
+443% +$729 ﹤0.01% 3864
2018
Q3 		$16K Buy
7
+6
+600% +$122 ﹤0.01% 6142
2018
Q2 		$1K Sell
1
-138
-99% -$2.31K ﹤0.01% 7209
2018
Q1 		$18K Buy
+139
New +$2.33K ﹤0.01% 3477
2017
Q4 		– Sell
-47
Closed -$1K – 6761
2017
Q3 		$1K Buy
+47
New +$787 ﹤0.01% 5595
2016
Q4 		– Sell
-100
Closed -$15K – 6590
2016
Q3 		$15K Buy
100
+70
+233% +$942 ﹤0.01% 3273
2016
Q2 		$2K Buy
30
+2
+7% +$19 ﹤0.01% 5033
2016
Q1 		$4K Sell
28
-9
-24% -$74 ﹤0.01% 4313
2015
Q4 		$6K Buy
37
+23
+164% +$230 ﹤0.01% 3775
2015
Q3 		$2K Buy
14
+7
+100% +$86 ﹤0.01% 4748
2015
Q2 		$1K Sell
7
-4
-36% -$43 ﹤0.01% 4821
2015
Q1 		$3K Sell
11
-41
-79% -$463 ﹤0.01% 3917
2014
Q4 		$5K Buy
+52
New +$615 ﹤0.01% 3131

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's VNDA Position: Q1 2026 in Review

Simplex Trading sold out of Vanda Pharmaceuticals (VNDA) in Q1 2026, closing a stake of 94,115 shares — an estimated $726K sold.

Simplex Trading first reported a position in VNDA in Q4 2014 and held it in 28 quarters. The position peaked at $1.55M in Q3 2018. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Simplex Trading reported no remaining Vanda Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 94,115 Vanda Pharmaceuticals shares in Q1 2026, an estimated $726K.
  • Simplex Trading first reported a position in Vanda Pharmaceuticals in Q4 2014 and held it in 28 quarters.
  • Simplex Trading's Vanda Pharmaceuticals position peaked at $1.55M in Q3 2018.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.